Prostacyclins in Cardiac Surgery: Coming of Age
- 25 December 2017
- journal article
- review article
- Published by SAGE Publications in Seminars in Cardiothoracic and Vascular Anesthesia
- Vol. 22 (3) , 306-323
Abstract
Prostacyclin (prostaglandin I2 [PGI2]) is an eicosanoid lipid mediator produced by the endothelial cells. It plays pivotal roles in vascular homeostasis by virtue of its potent vasodilatory and antithrombotic effects. Stable pharmacological analogues of PGI2 are used for treatment of pulmonary hypertension and right ventricular failure. PGI2 dose dependently inhibits platelet activation induced by adenosine-5′-diphosphate, arachidonic acid, collagen, and low-dose thrombin. This property has led to its use as an alternative to direct thrombin inhibitors in patients with type II heparin-induced thrombocytopenia (HIT) undergoing cardiac surgery. The aims of this review are the following: (1) to review the pharmacology of PGI2 and its derivatives, (2) to present the evidence for their use in pulmonary hypertension and right heart failure, and (3) to discuss their utility in the management of HIT in cardiac surgery.Keywords
This publication has 53 references indexed in Scilit:
- Quantitative interpretation of optical density measurements using PF4‐dependent enzyme‐immunoassaysJournal of Thrombosis and Haemostasis, 2008
- Inhaled iloprost to control pulmonary artery hypertension in patients undergoing mitral valve surgery: a prospective, randomized‐controlled trialActa Anaesthesiologica Scandinavica, 2007
- Inhaled iloprost in eight heart transplant recipients presenting with post‐bypass acute right ventricular dysfunctionActa Anaesthesiologica Scandinavica, 2006
- Treatment of pulmonary hypertension in patients undergoing cardiac surgery with cardiopulmonary bypass: a randomized, prospective, double-blind studyJournal of Cardiovascular Medicine, 2006
- Inhaled iloprost to control residual pulmonary hypertension following pulmonary endarterectomyEuropean Journal of Cardio-Thoracic Surgery, 2005
- Inhaled prostacyclin is safe, effective, and affordable in patients with pulmonary hypertension, right heart dysfunction, and refractory hypoxemia after cardiothoracic surgeryThe Journal of Thoracic and Cardiovascular Surgery, 2004
- Inhaled Nitric Oxide Reduces Pulmonary Vascular Resistance More Than Prostaglandin E1 During Heart TransplantationAnesthesia & Analgesia, 2000
- Inhaled Nitric Oxide Versus Intravenous Vasodilators in Severe Pulmonary Hypertension After Cardiac SurgeryAnesthesia & Analgesia, 1999
- Heparin-associated ThrombocytopeniaAnesthesiology, 1988
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976